Table 1. Clinical Details of Patients with Confirmed Hypersensitivity to Clavulanic Acid or Tazobactam.
| patient ID | age | gender | drug reaction interval (min) | reaction study interval (days) | reaction | clinical diagnosis |
|---|---|---|---|---|---|---|
| P1 | 44 | F | 20 | 240 | anaphylaxis | clavulanic acid hypersensitive (positive intradermal test) |
| P2 | 34 | F | 10 | 730 | urticaria | clavulanic acid hypersensitive (positive intradermal test) |
| P3 | 63 | M | 5 | 1460 | anaphylactic shock | clavulanic acid hypersensitive (positive intradermal test) |
| P4 | 34 | F | 12 (days) | 450 | maculopapular rash, fever | tazobactam hypersensitive (positive LTT) |